Loading…
Ardent Health, Inc. is projected to rise to $12.17 by 2027, a +29% move from its current price of $9.40. ARDT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.19 | $9.40 | $9.62 | +0.04% |
| May 30 | $9.11 | $9.41 | $9.71 | +0.09% |
| May 31 | $9.05 | $9.41 | $9.79 | +0.13% |
| Jun 1 | $9.00 | $9.42 | $9.85 | +0.18% |
| Jun 2 | $8.96 | $9.42 | $9.91 | +0.22% |
| Jun 3 | $8.92 | $9.43 | $9.96 | +0.27% |
| Jun 4 | $8.88 | $9.43 | $10.01 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.88 | $9.43 | $10.01 | +0.31% |
| Week 2 | $8.69 | $9.46 | $10.29 | +0.62% |
| Week 3 | $8.56 | $9.49 | $10.52 | +0.94% |
| Week 4 | $8.45 | $9.52 | $10.72 | +1.25% |
| Week 5 | $8.36 | $9.55 | $10.91 | +1.57% |
| Week 6 | $8.28 | $9.58 | $11.08 | +1.89% |
| Week 7 | $8.20 | $9.61 | $11.25 | +2.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings.
It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals.
Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C. The company was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. It was founded in 2001 and is based in Brentwood, Tennessee.
ARDT trades under the symbol ARDT and is currently priced at $9.23, with a market cap of $1.32B and a rank of 2321.
The current price sits below the 50-day moving average of $9.43 and the 200-day moving average of $10.66, indicating softer near-term momentum.
The price is near support at $9.21 and resistance at $10.32, with a 30-day trading range of $7.89 to $10.80. The long-run forecast shows a neutral stance for 2026 at an average of $9.23 with a 0 ROI, followed by bullish growth in subsequent years, culminating in strong upside by 2050 with an average near $68.99.
A major floor 13.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.0% away) — a key level to hold.
The nearest ceiling, 9.8% above — a clean break opens room to run.
A major ceiling 14.4% above — clearing it would confirm fresh momentum.
Key ARDT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARDT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.32 | Buy | $9.41 | Sell |
| MA 10 | $9.68 | Sell | $9.56 | Sell |
| MA 20 | $9.79 | Sell | $9.66 | Sell |
| MA 50 | $9.43 | Sell | $9.56 | Sell |
| MA 100 | $9.23 | Buy | $9.68 | Sell |
| MA 200 | $10.64 | Sell | $10.49 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.40 | Neutral |
| Stoch RSI (14) | 21.16 | Neutral |
| CCI (20) | -87.20 | Neutral |
| Williams %R (14) | -82.88 | Info |
| MACD (12,26,9) | -0.11 | Sell |
| ROC (12) | -7.02 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 17.12 | Buy |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | -0.42 | Sell |
| Ultimate (7,14,28) | 32.86 | Neutral |
| Momentum (10) | -0.67 | Sell |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 9.08 | Buy |
| ADX (14) | 13.20 | Neutral |
| ATR (14) | 0.21 | Info |
Bearish sentiment dominates the near term, with RSI14 at 40.
The stock is trading below its SMA50 of $9.43 and SMA200 of $10.66, signaling weaker momentum versus near-term and longer-term trends.
Key levels: support at $9.21 and resistance at $10.32, and the 30-day range spans from $7.89 to $10.80.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.17 | $9.40 | $13.06 | 0% | Neutral | |
| $9.82 | $12.17 | $15.89 | +29% | Bullish | |
| $10.30 | $13.06 | $17.57 | +39% | Bullish | |
| $10.70 | $13.81 | $19.04 | +47% | Bullish | |
| $11.69 | $15.34 | $21.58 | +63% | Bullish | |
| $12.53 | $16.68 | $23.88 | +77% | Bullish | |
| $14.76 | $19.92 | $28.99 | +112% | Bullish | |
| $16.69 | $22.82 | $33.69 | +143% | Bullish | |
| $17.48 | $24.19 | $36.21 | +157% | Bullish | |
| $17.95 | $25.13 | $38.10 | +167% | Bullish | |
| $26.62 | $39.28 | $62.81 | +318% | Bullish | |
| $44.83 | $72.23 | $124.96 | +668% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.17 | $9.40 | $11.00 | +0.00% |
| June 2026 | $8.09 | $9.47 | $11.31 | +0.71% |
| July 2026 | $8.31 | $9.79 | $11.83 | +3.41% |
| August 2026 | $8.32 | $9.86 | $12.02 | +0.72% |
| September 2026 | $8.29 | $9.86 | $12.11 | +0.04% |
| October 2026 | $8.55 | $10.22 | $12.62 | +3.59% |
| November 2026 | $8.78 | $10.52 | $13.07 | +3.00% |
| December 2026 | $8.70 | $10.46 | $13.06 | -0.59% |
Click any year to see its month-by-month ARDT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ARDT to range from $8.17 to $13.06 through 2026. The $9.40 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ARDT price prediction for 2027 points to an average of $12.17 (low $9.82, high $15.89) — a potential gain of +29% on today's $9.40. Buyers look set to stay in control over this stretch.
In 2028, ARDT is projected to trade between $10.30 and $17.57, averaging $13.06 — a potential gain of +39% from today's $9.40. That is up +7% on the projected 2027 average. Momentum favours further upside here.
Ardent Health, Inc.'s 2029 outlook centres on $13.81, within a $10.70 to $19.04 range. That is up +6% on the projected 2028 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ARDT could reach as high as $21.58, with a base case around $15.34 and support toward $11.69 — roughly +63% from $9.40. Momentum favours further upside here.
Expect ARDT to range from $12.53 to $23.88 through 2031. The $16.68 average target implies a +77% move from current prices. That is up +9% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ARDT price prediction for 2032 points to an average of $19.92 (low $14.76, high $28.99) — a potential gain of +112% on today's $9.40. Momentum favours further upside here.
In 2033, ARDT is projected to trade between $16.69 and $33.69, averaging $22.82 — a potential gain of +143% from today's $9.40. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Ardent Health, Inc.'s 2034 outlook centres on $24.19, within a $17.48 to $36.21 range. That is up +6% on the projected 2033 average. That marks a +157% change versus current levels. Momentum favours further upside here.
By 2035, ARDT could reach as high as $38.10, with a base case around $25.13 and support toward $17.95 — roughly +167% from $9.40. Buyers look set to stay in control over this stretch.
Expect ARDT to range from $26.62 to $62.81 through 2040. The $39.28 average target implies a +318% move from current prices. That is up +56% on the projected 2035 average. Momentum favours further upside here.
The ARDT price prediction for 2050 points to an average of $72.23 (low $44.83, high $124.96) — a potential gain of +668% on today's $9.40. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARDT today (≈ 106.382979 ARDT) could be worth
$7,684.15
+$6,684.15 (+668%) by 2050 · US Dollar
Based on the average projected ARDT price of $72.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARDTwould be worth at today's price.
$1,000 invested in ARDT on May 27, 2025 (≈ 67.249496 ARDT) would be worth
$632.15
-$367.85 (-36.8%) today · 0.63× · US Dollar
Based on a ARDT entry price of $14.87 vs. today's $9.4.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.45 | $994.71 | -0.5% |
| 1 month ago | $10.04 | $936.25 | -6.4% |
| 3 months ago | $9.48 | $991.56 | -0.8% |
| 6 months ago | $8.78 | $1,070.62 | +7.1% |
| 1 year ago | $14.87 | $632.15 | -36.8% |
| All time (1.9y) ago | $16.06 | $585.31 | -41.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARDT forecast.
Our base-case forecast reaches $19.00 around 2032.
Implied market cap at $19.00: $2.72B
2026 shows an average price of $9.23 with a min of $8.17 and a max of $12.87 and a ROI of 0, indicating a Neutral sentiment.
From 2027 through 2031, the forecast turns bullish with a sequence of rising averages: 2027 avg $12.00, min $9.63, max $15.76, ROI 30; 2028 avg $12.79, min $10.03, max $17.35, ROI 38.6; 2029 avg $13.41, min $10.31, max $18.64, ROI 45.2; 2030 avg $14.97, min $11.32, max $21.27, ROI 62.2; 2031 avg $16.14, min $12.02, max $23.37, ROI 74.9.
The momentum continues into 2032-2035 with 2032 avg $19.30, min $14.15, max $28.40, ROI 109; 2033 avg $22.34, min $16.17, max $33.39, ROI 142.1; 2034 avg $23.43, min $16.74, max $35.52, ROI 153.8; 2035 avg $24.15, min $17.04, max $37.10, ROI 161.7.
In 2040 the forecast shows an average of $37.85 (min $25.25, max $61.45) with ROI of 310.1 and bullish sentiment. By 2050 the average is projected to be $68.99 (min $41.86, max $121.55) with ROI of 647.5 and bullish sentiment.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $14.97, a minimum of $11.32, a maximum of $21.27, and a forecasted ROI of 62.2 with bullish sentiment.
Long-term forecasts show bullish sentiment from 2027 onward with rising averages and higher ROIs (e.g., 30 in 2027, 62.2 in 2030, up to 647.5 by 2050). The 2026 forecast is Neutral with an average of $9.23 and ROI of 0. However, the near term is currently Bearish and these figures are estimates, not guarantees.
The 2050 maximum forecast is $121.55, which is near $120. The 2050 average is $68.99 with a forecasted ROI of 647.5, and sentiment bullish.
Current price is $9.23 and market cap is $1.32B. The rank by market cap is 2321.
The 30-day picture is Bearish, with RSI(14) at 40. The stock trades below the SMA50 of $9.43 and SMA200 of $10.66, with support at $9.21 and resistance at $10.32. The 30-day trading range is $7.89 to $10.80.
Ardent Health, Inc. Community Discussion
0Share your Ardent Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.